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Abstract Induced pluripotent stem cell (iPSC)-derived
retinal pigment epithelium (RPE) has widely been appre-
ciated as a promising tool to model human ocular disease
emanating from primary RPE pathology. Here, we describe
the successful reprogramming of adult human dermal
fibroblasts to iPSCs and their differentiation to pure
expandable RPE cells with structural and functional fea-
tures characteristic for native RPE. Fibroblast cultures were
established from skin biopsy material and subsequently
reprogrammed following polycistronic lentiviral transduc-
tion with OCT4, SOX2, KLF4 and L-Myc. Fibroblast-
derived iPSCs showed typical morphology, chromosomal
integrity and a distinctive stem cell marker profile. Sub-
sequent differentiation resulted in expandable pigmented
hexagonal RPE cells. The cells revealed stable RNA
expression of mature RPE markers RPE65, RLBP and
BEST1. Immunolabelling verified localisation of BEST1 at
the basolateral plasma membrane, and scanning electron
microscopy showed typical microvilli at the apical side of
iPSC-derived RPE cells. Transepithelial resistance was
maintained at high levels during cell culture indicating
functional formation of tight junctions. Secretion capacity
was demonstrated for VEGF-A. Feeding of porcine pho-
toreceptor outer segments revealed the proper ability of
these cells for phagocytosis. IPSC-derived RPE cells lar-
gely maintained these properties after cryopreservation.
Together, our study underlines that adult dermal fibroblasts
can serve as a valuable resource for iPSC-derived RPE
with characteristics highly reminiscent of true RPE cells.
This will allow its broad application to establish cellular
models for RPE-related human diseases.
Keywords Induced pluripotent stem cell  Retinal
pigment epithelium  Dermal fibroblast  Bestrophin-1 
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Introduction
Induced pluripotent stem cells (iPSCs) have initially been
established from mouse and subsequently from human cells
(Takahashi and Yamanaka 2006; Takahashi et al. 2007),
the latter demonstrating the successful reprogramming of
human somatic cells into pluripotent cells resembling
human embryonic stem cells (hESCs). Since then, human
iPSCs (hiPSCs) have been appreciated as a promising
source for disease modelling, drug screening and cell-based
transplantation therapy in selected human degenerative
diseases (Yamanaka 2009; Egashira et al. 2013; Okano
et al. 2013).
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Degenerative disorders involving the retinal pigment
epithelium (RPE) are common in ocular diseases high-
lighting the crucial role of this post-mitotic cell layer in
retinal homoeostasis (Strauss 2005; Singh et al. 2013a).
Monogenic as well as complex RPE-related diseases, such
as age-related macular degeneration, are common causes of
blindness while therapeutic options are limited (Lim et al.
2012).
In vitro modelling of hiPSC-derived RPE cells has been
a focus of research in ophthalmic research. Access to
renewable sources of highly functional and expandable
human RPE is ideal for studying these cells and the dis-
eases affecting them (Du et al. 2011; Singh et al. 2013b).
Different protocols for the differentiation of human plu-
ripotent stem cells (hPSCs) into RPE have been described.
Acquired cells were reported to display characteristic
phenotypes as well as gene expression and exhibit key
physiological functions (Ukrohne et al. 2012; Buchholz
et al. 2013; Zhu et al. 2013; Rowland et al. 2013; Mekala
et al. 2013; Maruotti et al. 2013; Singh et al. 2013a). RPE
derived from hESCs has even reached the necessary stan-
dards for use in human clinical trials of cell-based trans-
plantation therapy (Schwartz et al. 2012). Key parameters
evaluated in many hPSC-RPE studies thus far include cell
morphology, gene and protein expression, transepithelial
resistance (TER) and photoreceptor outer segment (POS)
phagocytosis (Buchholz et al. 2009; Ukrohne et al. 2012;
Zhu et al. 2013; Singh et al. 2013a, b). Secretion capacities
were investigated into fewer studies, describing polarised
secretion of known biological factors like VEGF-A by
hiPSC-RPE cells (Singh et al. 2013a). It has recently been
shown that highly differentiated, pigmented hiPSC-RPE
monolayers can undergo only limited serial expansions
before losing key cytological and functional attributes due
to replicative senescence (Singh et al. 2013a). Importantly,
studies investigating cryostorability of hiPSC-RPE cells are
scarce up to this point. Moreover, many protocols for RPE
cell differentiation, if not the majority, use, e.g. neonatal
foreskin fibroblasts, neonatal keratinocytes or even foetal
lung fibroblast and foetal neural stem cells as a source, as it
seems more feasible to reprogram and differentiate
younger cells, due to their putatively higher plasticity
(Ukrohne et al. 2012; Buchholz et al. 2013; Zhu et al. 2013;
Maruotti et al. 2013).
In the present study, we report the successful repro-
gramming of human adult skin biopsy-derived fibroblasts
to iPSCs and their differentiation to expandable and cryo-
storable hiPSC-RPE cells. Establishing and optimising
such protocols will be particularly important for generating
specific RPE cell models from patients with various dis-
eases affecting the RPE. Our approach represents a further
step towards establishing a hiPSC-RPE cell repository
which yields pure populations of functional cells that
display main features of native RPE. Characterisation of
hiPSC-RPE cells during subcultivation has addressed
structural and functional key aspects, the occurrence of
replicative senescence and their cryostorability. We deep-
ened morphological examinations by scanning electron
microscopy. Furthermore, we emphasised protein expres-
sion and correct localisation of the RPE-specific marker
BEST1 in hiPSC-RPE cells as a high-quality measure of
proper differentiation.
Materials and Methods
Adult Human Dermal Fibroblasts
Biopsy material of healthy skin (4 mm) was obtained
according to standard protocols from the Department of
Dermatology, University Hospital Regensburg, Germany.
Dermal tissue was cut into 0.5-mm pieces and subsequently
seeded in 100-mm cell culture dishes in standard fibroblast
growth medium (Dulbecco’s modified Eagle’s medium
[DMEM] high-glucose with 4.5 g/l L-glutamine, supple-
mented with 10 % foetal bovine serum, 100 U/ml peni-
cillin and 0.1 mg/ml streptomycin (all Gibco by Life
Technologies, Darmstadt, Germany). After 10–15 days, an
outgrowth of single fibroblastoid-shaped cells was
observed. Cultures were maintained in humidified air (5 %
CO2) at 37 C, and medium was changed twice a week.
After reaching confluency, cells were detached using
trypsin–EDTA (Gibco by Life Technologies, Darmstadt,
Germany) and subcultured in 75-cm2 cell culture flasks
with fibroblast growth medium.
Reprogramming and Expansion of hiPSC
Human iPSCs were obtained via polycistronic lentiviral
transduction (Human STEMCCA Cre-Excisable Constitu-
tive Polycistronic [OKS/L-Myc] Lentivirus Reprogram-
ming Kit, Merck Millipore, Darmstadt, Germany)
following the manufacturer’s recommendations. Briefly,
human dermal fibroblasts (passage 4 or 5) were seeded in
6-well dishes at a density of 15,000 cells/well in fibroblast
growth medium 1 day prior to infection. The following
day, medium was changed and supplemented with polyb-
rene (6 lg/ml, Merck Millipore, Darmstadt, Germany).
Lentivirus was added with a multiplicity of infection
(MOI) of 50, and spinfection was conducted at 800 g for
1 h. Medium was then changed, and fresh polybrene and
lentivirus were added over night. After 5 days, infected
fibroblasts were detached with trypsin–EDTA and replated
on irradiated mouse embryonic fibroblasts (iMEFS, Merck
Millipore, Darmstadt, Germany). Medium was switched to
human embryonic stem cell (hESC) medium, containing
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DMEM/Ham’s F12, 2 mM L-glutamine, 20 % knockout
serum replacement, 0.1 mM non-essential amino acids (all
Gibco by Life Technologies, Darmstadt, Germany),
0.1 mM 2-mercaptoethanol (Merck Millipore, Darmstadt,
Germany), 20 ng/ml bFGF (Pepro Tech, Hamburg, Ger-
many), 50 mg/ml gentamicin (Sigma-Aldrich, Munich,
Germany) and 0.1 % Human iPS Reprogramming Boost
Supplement II (Merck Millipore, Darmstadt, Germany).
Medium was changed every other day. Human iPSC col-
onies appeared between day 15 and 20 and were picked
mechanically for monoclonal expansion under serum- and
feeder-free conditions on hESC-qualified Matrigel (BD
Biosciences, Heidelberg, Germany) in mTeSRTM1 medium
(Stemcell Technologies, Ko¨ln, Germany). Medium was
changed daily. For propagation of hiPSCs, enzymatic
passaging with dispase treatment (1 mg/ml, Stemcell
Technologies, Ko¨ln, Germany) was applied every 4–5 days
at splitting ratios of 1:3. For cryostorage at -190 C, cells
were kept in 90 % knockout serum replacement and 10 %
DMSO (AppliChem, Darmstadt, Germany).
RPE Differentiation and Cultivation
The protocol for RPE differentiation and cultivation was
based on Ukrohne et al. (2012) with minor modifications.
Human iPSCs were expanded to confluence in mTeSRTM1
maintenance medium for 12–14 days. Differentiation was
induced by switching hiPSC maintenance medium to RPE
medium containing knockout DMEM, 2 mM L-glutamine,
20 % knockout serum replacement, 0.1 mM non-essential
amino acids (all Gibco by Life Technologies, Darmstadt,
Germany), 0.1 mM b-mercaptoethanol, 100 U/ml penicil-
lin, 0.1 mg/ml streptomycin and 10 mM nicotinamide
(Sigma-Aldrich, Munich, Germany). Medium was changed
daily. Starting at week 4 of differentiation, 62 ng/ml acti-
vin A (Pepro Tech, Hamburg, Germany) was added to the
medium until pigmented cell clusters appeared within the
culture (within about 2 weeks). Consequently, clusters
enlarged progressively during the following 2–3 weeks and
were manually excised with a scalpel to enrich for iPSC-
RPE cells. Pigmented patches were enzymatically dis-
sected into single cells by Tryp-LE select (Gibco by Life
Technologies, Darmstadt, Germany) and replated on
growth factor-reduced (gfr-) Matrigel (dilution 1:30, BD
Biosciences, Heidelberg, Germany)-coated cell culture
plates in RPE medium without activin A. Within approx-
imately 4 weeks, cells had reached confluence and had
regained their characteristic morphology. They were then
detached with 1 mM EDTA in PBS (phosphate-buffered
saline, Gibco by Life Technologies, Darmstadt, Germany)
for 10 min followed by Tryp-LE select for 10 min and split
at ratios from 1:6 to 1:10 for subsequent expansion on gfr-
Matrigel-coated plates in RPE medium without activin A.
Medium was changed every other day, and passaging was
performed every 4–5 weeks.
For further analysis, hiPSC-RPE cells were cultivated on
12-well or 6-well transwell filter inserts (0.4-lm pore size,
Corning Costar by Sigma-Aldrich, Munich, Germany)
coated with gfr-Matrigel at a dilution of 1:30. For cryos-
torage at -190 C, cells were kept in CryoStorTMCS10
medium (Stemcell Technologies, Ko¨ln, Germany).
Reverse Transcription Polymerase Chain Reaction
(RT-PCR) and Quantitative (q)RT-PCR
Total RNA was isolated from cultured cells using the
RNeasy Mini Kit (Qiagen, Hilden, Germany) according to
the manufacturer’s recommendations. On-column DNase
digestion reliably removes genomic DNA contamination
(Roche, Mannheim, Germany). First-strand cDNAs from
1 lg of total RNA were synthesised using the RevertAid H
Minus First-Strand cDNA Synthesis Kit (Fermentas by
Thermo Fisher Scientific, Schwerte, Germany).
For RT-PCR, 50 ng of cDNA was used as templates for
PCR with Go Taq Polymerase (Promega, Mannheim,
Germany) at a final volume of 25 ll. Gene-specific primers
were designed online with the Primer3 programme (http://
simgene.com/Primer3) and are given in Supplemental
Table S1. PCR products were electrophoretically separated
in a 2 % agarose gel. All genes were amplified for a total of
35 cycles, and the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) served as control for
RNA integrity. Human iPSCs were further characterised
with the hES/iPS Cell Pluripotency RT-PCR Kit (Applied
Stem Cell, Menlo Park, USA).
For qRT-PCR analysis, first-strand cDNA was obtained
from 2 lg total RNA using the high-capacity cDNA RT Kit
with RNase Inhibitor (Life Technologies, Darmstadt,
Germany). Expression of pluripotency markers and deter-
mination of trilineage differentiation potential were eval-
uated for hiPSCs with the TaqMan hPSC ScorecardTM
Panel (384 well, ViiA7, Life Technologies, Darmstadt,
Germany) following the company’s guidelines and using
its cloud-based online analysis software.
Immunofluorescence
For immunofluorescence analysis, hiPSCs were cultured on
hESC-qualified Matrigel-coated glass chamber slides for
2–3 days in mTeSRTM1 maintenance medium. Cells were
washed twice with PBS, pH 7.4 and fixed with 4 % para-
formaldehyde ([PFA] in PBS, Roth, Karlsruhe, Germany)
for 10 min followed by three washing steps with PBS. To
reduce unspecific background, cells were blocked for
30 min in PBS containing 0.3 % Triton X-100 (Sigma-
Aldrich, Munich, Germany) and 10 % goat serum
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(Calbiochem, Darmstadt, Germany) at room temperature.
Staining with primary antibody was performed in PBS
supplemented with 0.1 % Triton X-100 and 2.5 % goat
serum overnight at 4 C. A list of primary antibodies and
the respective dilutions are given in Supplemental Table
S2. After three washing steps with PBS, secondary anti-
bodies were added for 2 h at room temperature, together
with a 1:1,000 dilution of 40,6-diamidino-2-phenylindole
(DAPI) dilactate (Sigma-Aldrich, Munich, Germany) for
nuclei staining. As a negative control, each staining was
carried out without the respective primary antibody (data
not shown). In addition, to ensure specific of stem cell
markers, human embryonic kidney 293 (HEK) cells were
stained as negative controls (data not shown). After stain-
ing, cells were rinsed, mounted with DakoCytomation
fluorescent mounting medium (DAKO, Hamburg, Ger-
many) and viewed with a fluorescence microscope (Axio-
skop 2 mot plus, Zeiss, Go¨ttingen, Germany).
Human iPSC-derived RPE cells cultured on either gfr-
Matrigel-coated 12-well transwell filter inserts (0.4 lm
pore) or gfr-Matrigel-coated glass cover slips were washed
twice with PBS and fixed with 4 % PFA for 10 min from
both sides of the transwell filter membrane. Reaction was
stopped with 100 mM glycin (Merk, Darmstadt, Germany)
in PBS. Cells were rinsed, and blocking solution (10 %
normal goat serum, 0.2 % Triton X-100, 0.1 % purified
BSA [Gibco by Life Technologies, Darmstadt, Germany],
0.05 % Tween 20 [AppliChem, Darmstadt, Germany], in
PBS) was added for 1.5 h at room temperature. Primary
antibodies and working dilutions are listed in Supplemental
Table S2. After three washing steps in PBS buffer solution
(containing 0.2 % Triton X-100, 0.1 % purified BSA,
0.05 % Tween 20), secondary antibodies (Supplemental
Table S2) were incubated over night at 4 C. Cells were
rinsed with buffer solution for 20 min and with PBS only
for 10 min at room temperature. Nuclei were stained with a
1:1,000 dilution of 40,6-diamidino-2-phenylindole (DAPI)
dilactate for 20 min. Cells were finally rinsed and mounted.
Transwell filter membranes were excised with a scalpel and
placed on object slides. For negative control, the procedure
was carried out omitting the primary antibody (data not
shown). Human iPSCs served as negative control and were
stained according to this protocol to ensure RPE specificity
of protein markers (data not shown). Cells were examined
using confocal microscope LSM510 (Zeiss, Go¨ttingen,
Germany). Images were recorded at intensity levels below
saturation, estimated by intensity analysis module.
Surface Biotinylation, SDS Page and Western Blot
Analysis
For biotinylation of plasma membrane proteins, a fresh solu-
tion of EZ-Link Sulfo-NHS-SS-Biotin (Thermo Fisher
Scientific, Schwerte, Germany) was prepared at a concentra-
tion of 1 mg/ml in ice-cold PBS. Human iPS-derived RPE
cells grown on 6-well transwell filters for 3 months were
washed 3 times with ice-cold PBS. Biotin/PBS solution was
added to the basal and the apical chamber followed by incu-
bation for 30 min in the cold. Biotin reaction was stopped by
adding 100 ll of stop solution (Life Technologies, Darmstadt,
Germany) and extensive washing with ice-cold PBS.
Cells from a single 6-well transwell filter were collected in
1 ml lysis buffer (50 mM Tris, pH 7.5, 5 mM EDTA, 15 mM
NaCl, 1 % Triton, 1 9 Protease inhibitor cocktail
(#04693116001, Roche, Mannheim, Germany) and homog-
enised by passing the lysate 8 times through a 25-gauge
needle attached to a syringe. After incubation for 30 min at
4 C, lysates were centrifuged for 15 min at 13,000 g.
Streptavidin beads (100 ll, Life Technologies, Darmstadt,
Germany) were added to the supernatant and incubated on a
rotating wheel over night at 4 C. Beads were washed 5 times
with cold lysis buffer, and biotinylated proteins were eluted
by boiling the sample for 5 min at 95 C in SDS sample
buffer containing 50 mM Tris-HCl pH 6.8, 2 % SDS, 10 %
glycerol, 1 % b-mercaptoethanol, 12.5 mM EDTA and
0.02 % bromophenol blue. Proteins were separated by SDS-
polyacrylamide gel electrophoresis on 10 % gels and subse-
quently transferred onto PVDF membranes (Merck Millipore,
Darmstadt, Germany). After blocking in PBS (pH 7.4) con-
taining 4 % non-fat dry milk, membranes were incubated
with primary antibodies at 4 C overnight (mouse anti-human
bestrophin-1 monoclonal antibody [E6-6, ab2182, Abcam,
Cambridge, UK], dilution 1:2,500, and mouse monoclonal
antibody against b-actin [#5441, Sigma-Aldrich, Munich,
Germany], dilution 1:10,000). Washing steps were performed
with PBS containing 0.05 % Tween-20, followed by incu-
bation with a 1:10,000 dilution of HRP-conjugated secondary
antibody (Calbiochem/Merck, Darmstadt, Germany) for 2 h
at room temperature. After a final washing with PBS con-
taining 0.05 % Tween-20, protein labelling was visualised by
enhanced chemiluminescence (ECL) using AGFA medical
X-ray film (AGFA, Ko¨ln, Germany).
Scanning Electron Microscopy (SEM)
For detailed visualisation, hiPSC-RPE cells were viewed
both in high-vacuum (high-vac) and low-vacuum (low-vac)
SEM mode. Human iPSC-RPE cells cultured on transwell
filters for 3 months were rinsed once with PBS and fixed
for 30 min at room temperature with 2.5 % glutaraldehyde
(Serva, Heidelberg, Germany) in 0.1 M Soerensen buffer,
pH 7.4 (Merck, Darmstadt, Germany) and aqua bidest.
Then, cells were washed 3 times with 0.1 M Soerensen
buffer, pH 7.4 for 5 min at room temperature.
For low-vac SEM, fixated cells were rinsed with aqua
bidest for salt removal, brought on stubs via Leit-Tabs
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(Science Services, Munich, Germany) and analysed in
moist condition with the FEI Quanta 400 FEG (FEI Deu-
tschland GmbH, Kassel, Germany) in low-vac mode
(LFD ? EDX-PLA; 4.0 kV, Spot 4, WD & 10 mm,
1.5 Torr, tilt 30).
For high-vac SEM, fixated cells underwent serial dehy-
dration via increasing ethanol concentrations (30–96 %
EtOH). After treatment with the critical point dryer Balzers
CPD 030 (BAL-TEC AG, Leica, Wetzlar, Germany), and
positioning on stubs via Leit-Tabs (Science Services,
Munich, Germany), cells were sputtered with platinum
twice for 30 s at 30 mA in 50 mm distance (BAL-TEC SCD
005, BAL-TEC AG, Leica, Wetzlar, Germany). Cells were
kept in the exsiccator and investigated in dry condition with
the FEI Quanta 400 FEG in high-vac mode (4.0 kV, Spot 3,
WD & 6 mm, B10-4 Torr, tilt 30).
Chromosome Preparation and Karyotyping
For numerical and structural chromosome analyses of
dermal fibroblasts and hiPSCs, high-resolution karyotyping
was performed. Fibroblasts were grown in T25 culture
flasks in fibroblast growth medium. Human iPSCs were
cultivated in T25 flasks coated with hESC-qualified Ma-
trigel in mTeSRTM1 maintenance medium. Cells were
synchronised using thymidine solution (Sigma-Aldrich,
Munich, Germany) and subsequently treated with colcemid
(Roche, Mannheim, Germany) for 10 min at 37 C. After
detachment with trypsin–EDTA, cells were centrifuged,
and the cell pellet was re-suspended and maintained in
hypotonic solution (75 mM KCl) for 12 min at 37 C.
Cells were then fixed in methanol and acetic acid. Meta-
phase spreads were prepared on cover slips, dried overnight
and Giemsa stained (Sigma-Aldrich, Munich, Germany)
after trypsin pre-treatment.
Transepithelial Resistance (TER) Measurements
For functional assessment, TER of hiPSC-RPE monolayers
cultured on gfr-Matrigel-coated transwell filters was mea-
sured using an epithelial voltohmmeter (EVOMX) fol-
lowing the manufacturer’s instructions (World Precision
Instruments, Berlin, Germany). Briefly, electrodes were
sterilized with 70 % ethanol, rinsed in 150 mM NaCl
solution and placed in the transwell filter with the longer
voltage electrode positioned in the lower chamber touching
the bottom of the dish while the shorter current electrode
was placed in the upper chamber. Net TER was calculated
from TER recordings by subtracting background mea-
surements obtained from gfr-Matrigel-coated transwell
filters without cells. TER measurements were obtained by
multiplying net TER values with the surface area of the
transwell filters and reported as X*cm2.
VEGF Secretion
To determine secretion properties, hiPSC-RPE monolayers
were grown for 2 months on gfr-Matrigel-coated 12-well
transwell filters. Apical and basal VEGF-A levels were
measured using the commercially available Human VEGF
Quantikine ELISA Kit (#DVE00, R&D Systems, Wiesba-
den-Nordenstadt, Germany) in accordance with the man-
ufacturer’s instructions. In brief, 24-h-old extracellular
RPE medium was taken from the apical and basal chamber.
Microplate reading was performed with the FLUOstar
OPTIMA (BMG Labtech, Ortenberg, Germany). Net
VEGF-A was calculated by subtracting unused medium
(negative control).
Photoreceptor Outer Segment (POS) Phagocytosis
Human iPSC-RPE cells were fed porcine POS which were
obtained from porcine retinae after homogenisation with
20 % sucrose (Merck, Darmstadt, Germany) and 1 x Pro-
tease inhibitor cocktail. After centrifugation for 5 min at
500 g in 4 C, the supernatant was again homogenised with
20 % sucrose and protease inhibitor and consequently
separated by density gradient centrifugation (100,000 g,
120 min, 4 C, without brake). The fraction containing
POS was transferred into 11-ml tubes (BD Biosciences,
Heidelberg, Germany), rinsed with 0.02 M Tris buffer and
centrifuged at 10,000 g for 10 min without brake. The
pellet was re-suspended in cryosolution containing 10 mM
phosphate buffer, 0.1 mM NaCl and 2.5 % sucrose. POS
were counted using the Neubauer counting chamber, ali-
quoted and stored at -80 C.
Prior to feeding, POS were labelled with Oregon green
488 (OG488, Molecular probes by Life Technologies,
Darmstadt, Germany). POS were thawed, pelleted
(10,000 g, 3 min, 4 C) and re-suspended in 100 ll 0.1 M
bicarbonate buffer, pH 8.3. After adding 10 ll OG488 in
1:100 diluted DMSO, POS were vortexed and incubated on
a shaker for 90 min in the dark at 4 C. After two washing
steps with PBS, the cells were pelleted at 10,000 g and
blocked with serum-containing medium on a shaker for
20 min in the dark at 4 C. Then, POS were centrifuged
(10,000 g, 3 min, 4 C), and the labelled POS were re-
suspended in fresh Opti-MEM (Gibco by Life Technolo-
gies, Darmstadt, Germany).
To investigate phagocytotic uptake and degradation in a
timeline experiment, hiPSC-RPE cells cultured on trans-
well filters for 2 months were incubated with labelled POS
in RPE medium, applying a concentration of 20 POS per
cell for 90 min, 6 and 24 h. Cryostored hiPSC-RPE cells
cultured on transwell filters for 2 months were incubated
with 20 POS per cell for 24 h. Feeding experiments were
analysed by confocal microscopy. Briefly, cells were
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thoroughly washed with PBS to remove non-incorporated
POS and immunostained with rabbit anti-human ZO-1
polyclonal antibody (#617300, Zymed Laboratories by Life
Technologies, Darmstadt, Germany). Cells were subse-
quently mounted and examined using confocal microscope
LSM510. Images were recorded at intensity levels below
saturation, estimated by intensity analysis module. Confo-
cal images were quantitatively analysed using an ImageJ
software package (version 1.47v) following procedures
described by Abramoff et al. (2004). For analysis of POS
phagocytosis, confocal image files (z-stacks) taken with the
green channel were loaded into ImageJ and submitted to
Z-Project Sum Slices command. Next, threshold levels
were determined by analysing the histogram of the entire
image. An equal threshold level was used for all follow-up
images. The total number of POS was counted using
Analyze Particles command.
Statistics
Data throughout the manuscript are expressed as
mean ± standard deviation (SD). If compared using the
unpaired Student’s t test, significance was reported for
p values B0.05.
Results
Human iPSCs Derived from Adult Human Dermal
Fibroblasts Reveal Chromosomal Integrity
and Distinctive Stem Cell Properties
Skin biopsies from a total of five unrelated probands were
taken in the course of this study. Here, we present an in-
depth characterisation of a cell line derived from a 26-year-
old healthy female donor (‘‘WT1’’). After 15 days in
culture, dermal fibroblasts sprouted from the skin biopsy
and were subcultured (Fig. 1a). At passage 5, reprogram-
ming experiments were initiated with polycistronic len-
tiviral transduction. A total of five individual clones
(named hiPSC_WT1c1 to c5) were subcultured in serum-
free and feeder-free conditions for at least 35 passages. The
hiPSCs showed typical hESC-like morphology (Fig. 1b),
and there were no signs of increased differentiation or
slower growth in higher passages. Karyotyping demon-
strated normal karyotype for both fibroblast (passage 6,
data not shown) and the hiPSC lines at passage 9 (Fig. 1c).
At passage 21, hiPSCs revealed a mosaic with 47,XXX in
one clone and a mosaic with trisomy 8 in a second clone
(data not shown). Therefore, subsequent differentiation of
hiPSCs was initiated before passage 10 to ensure chro-
mosomal integrity.
RT-PCR and qRT-PCR experiments with hiPSC RNA
showed an expression profile characteristic for stem cell
markers (Fig. 2a, Supplemental Figure S1). For RT-PCR,
hiPSCs was compared to its originating dermal fibroblast
cell line (Fig. 2a). The iPSCs were positive for endogenous
POU class 5 homeobox 1 (OCT4), SRY [sex determining
region Y]-box 2 (SOX2), Nanog homeobox (NANOG),
telomerase reverse transcriptase (TERT), undifferentiated
embryonic cell transcription factor 1 (UTF1), zinc finger
protein (REX1) and DNA (cytosine-5-)-methyltransferase 3
beta (DNMT3B). In contrast, fibroblast RNA was negative
for the stem cell markers tested except for OCT4 which
was weakly expressed. Collagen type I, alpha 1 (COL1A1)
was strongly expressed in fibroblasts and showed a minor
expression in hiPSCs while housekeeping gene glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) was
strongly expressed in both cell lines.
The TaqMan hPSC Scorecard Panel evaluates pluripo-
tency and detects germ layer bias by providing a pre-
manufactured qRT-PCR assay and special cloud-based data
Fig. 1 Morphology and chromosomal integrity of adult human
dermal fibroblast-derived hiPSCs. a Outgrowth of human dermal
fibroblasts from skin biopsy tissue obtained from a healthy 26-year-
old female donor (‘‘WT1’’). b Fibroblast-derived hiPSC_WT1c1 at
passage 9 show characteristic hESC-like morphology with round,
sharp-edged colonies and tightly packed cells. Enlarged section:
hiPSCs reveal prominent nucleoli with a high ratio of nucleus to
cytoplasm volume. c Karyotype of hiPSC_WT1c1 at passage 9 shows
a normal karyogram (46, XX). There are no structural or numerical
aberrations detectable. Scale bars 100 lm
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analysis software. Analysing hiPSC RNA, pluripotency
marker expression was comparable to the reference stan-
dard given in the analysis software (Supplemental Figure
S1). Regarding germ layer markers, a comparison with
standard hiPSC lines revealed downregulated expression
for endoderm markers (1.5-fold) and highly significant for
ectoderm markers (2.69-fold). Mesoderm markers were
slightly downregulated but not significantly altered to
standard (0.36-fold) (Supplemental Figure S1).
Immunofluorescence labelling of hiPSC colonies
revealed expression of the four key pluripotency markers
including OCT4, NANOG, SSEA3 and TRA-1-60 (Fig. 2b–
e). Nuclei were positively stained with DAPI (blue). In
contrast, HEK 293 cells serving as negative control showed
no expression of stem cell markers (data not shown).
RPE Differentiation into Pure and Expandable
hiPSC-RPE Cells
About 8 weeks after induction of RPE cell differentiation,
pigmented clusters of hexagonal cells were visible (Fig. 3a,
b). Human iPSC-RPE cells were subcultured both on gfr-
Matrigel-coated cell culture plates and gfr-Matrigel-coated
transwell filters. After 6 weeks on culture plates, conditions
for hiPSC-RPE cells seemed less favourable when com-
pared to transwell filters where cells could be grown for
6 months without passaging (data not shown). The iPSC-
RPE lost pigmentation after initial passaging, which usu-
ally returned during the following 4–6 weeks. In two of the
five cell lines analysed pigmentation never returned.
Human iPSC-RPE Cells Demonstrate High-Quality,
High-Purity and Adequate RPE Marker Expression
To analyse hiPSC-RPE cell morphology, cell culture
preparations were viewed both in high-vac and low-vac
scanning electron microscopy mode. SEM of hiPSC-RPE
grown on transwell filter revealed the typical hexagonal
cell shape (moist condition, low vac, data not shown) and
the presence of characteristic microvilli at the apical side of
the cells (dry condition, high vac, Fig. 3c).
An RNA expression profile for characteristic mature
RPE markers was established by RT-PCR for hiPSC-RPE
cells in comparison with its originating hiPSCs and native
human RPE (Fig. 4a). Results showed strong expression of
retinal pigment epithelium-specific protein 65 kDa
(RPE65), bestrophin-1 (BEST1), retinaldehyde-binding
protein 1 (RLBP1) and the melanogenesis marker tyrosi-
nase (TYR) in hiPSC-RPE cells and native RPE, but no or
only weak expression for BEST1 in hiPSCs. Stem cell
marker NANOG was weakly present in differentiated
hiPSC-RPE and in native human RPE but showed a strong
expression in hiPSCs.
Immunostaining demonstrated the presence of RPE-
specific marker proteins BEST1 and tight junction marker
zonula occludens 1 (ZO-1) (Fig. 4b, c). Whole 12-well
filter inserts were stained and in total analysed under the
microscope. Every single cell in the monolayer culture was
positively stained for these 2 markers, demonstrating
100 % purity of the hiPSC-RPE cell culture with homo-
geneous staining patterns. When polarised on transwell
Fig. 2 RNA and protein expression profiling of adult human dermal
fibroblast-derived hiPSCs. a RT-PCR analyses expression of several
typical stem cell markers (OCT4, SOX2, NANOG, TERT, UTF1,
REX1, DNMT3B) and the fibroblast marker COL1A1 in total RNA
derived from adult human dermal fibroblasts (lane 1) and hiPSC cell
line hiPSC_WT1c1 (lane 2). RT-PCR was performed with gene-
specific primers as given in Supplemental Table S1 and
electrophoretically separated in a 2 % agarose gel. The housekeeping
gene GAPDH was used to control for RNA integrity. Total RNA
without reverse transcriptase served as negative control (lane 3). b–
e For immunofluorescence analysis of stem cell marker expression,
hiPSC_WT1c1 at passage 9 were stained against NANOG (green)
(b), OCT4 (green) (c), SSEA3 (red) (d), TRA-1-60 (green) (e).
Nuclei were stained with DAPI (blue, below). Scale bars 100 lm
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Fig. 3 Morphology of hiPSC-RPE cells. a In cell line, hiPSC-
RPE_WT1c1 pigmented cell clusters appear within 8 weeks after
induction of RPE differentiation in hESC-qualified Matrigel-coated
6-well culture plates. b The pigmented cells were investigated via
inverted light microscope and show a typical hexagonal morphology.
Scale bar 100 lm. c Scanning electron microscopy (SEM) in high-
vac mode reveals characteristic, apical microvilli. Note the vesicle-
like structure (asterisk). Scale bar 1 lm
Fig. 4 Expression profiling of hiPSC-RPE cells. a RNA expression
profiling was done for mature RPE markers (RPE65, BEST1, RLBP1),
the melanogenesis marker TYR and the stem cell marker NANOG in
total RNA derived from hiPSCs (lane 1), hiPSC-RPE (lane 2) and native
RPE (lane 3). RT-PCR was performed with gene-specific primers as
given in Supplemental Table S1 and electrophoretically separated in a
2 % agarose gel. The housekeeping gene GAPDH was used to control
for RNA integrity. Total RNA without reverse transcriptase served as
negative control (lane 4). b Antibody labelling against RPE-specific
marker BEST1 (green) and tight junction marker zonula occludens 1
(ZO-1, red). Endogenous BEST1 is targeted to the basolateral plasma
membrane, whereas ZO-1 shows apical localisation. Shown are x–y and
x–z projections of monolayers of polarised hiPSC-RPE_WT1c1,
passage 4, grown on transwell filters for 2 months. Scale bars 20 lm.
c Immunofluorescence stainings against BEST1 (green) and ZO-1 (red)
in hiPSC-RPE cells cultured unpolarised on glass cover slides.
Endogenous BEST1 protein localises less efficiently to the basolateral
plasma membrane, whereas ZO-1 shows the typical apical localisation.
Shown are x–y and x–z projections of monolayers of unpolarised hiPSC-
RPE_WT1c1, passage 4, grown on glass cover slips for 2 months. Scale
bars 20 lm. d Cell surface expression of BEST1 was shown by surface
protein biotinylation, followed by precipitation with streptavidin.
Immunoblot analysis with BEST1 monoclonal antibody demonstrates a
substantial staining in the biotinylated cell membrane fraction (biotin).
Co-staining with anti beta-actin (ACTB) served as negative control
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filters for 2 months at passage 4, confocal microscopy
verified localisation of BEST1 protein at the basolateral
plasma membrane and ZO-1 at the apical side of hiPSC-
RPE cells (Fig. 4b). When hiPSC-RPE cells were cultured
unpolarised on glass cover slips for 2 months at passage 4,
BEST1 protein was found mostly in the cytosol and less
efficiently localised to the plasma membrane (Fig. 4c).
Also, gaps in the monolayer due to cell loss (data not
shown) were more often observed in unpolarised versus
polarised hiPSC-RPE cells (Fig. 4b, c). As a negative
control, hiPSC were also stained against BEST and ZO-1
protein and revealed no expression of the RPE markers
(data not shown).
To determine whether BEST1 protein is truly present at
the plasma membrane, surface protein biotinylation was
performed to label plasma membrane proteins in hiPSC-
RPE cells. Immunoblot analysis showed a substantial
staining of BEST1 protein in the biotinylated fraction
(Fig. 4d). An antibody against the intracellular protein
beta-actin (ACTB) served as negative control and revealed
no signal. Interestingly, hiPSC-RPE cells at passage 6 after
2 months of cultivation on transwell filters also revealed
BEST1- and ZO-1-positive cells, but BEST1 was found
diffusely in the cytosol and less efficiently localised to the
plasma membrane (data not shown).
Human iPSC-RPE Cells Demonstrate Key RPE
Functions
To address a fundamental aspect of RPE cell function,
Oregon green-labelled POS were fed in a timeline experi-
ment (1.5, 6, 24 h) at a concentration of 20 POS per cell to
hiPSC-RPE cells cultured on transwell filters for 2 months.
Phagocytotic uptake and degradation activity was moni-
tored by confocal microscopy (Fig. 5a). In addition,
incorporated POS were recorded automatically in the
confocal images for quantitative follow-up (Fig. 5b). After
1.5 h, POS became incorporated by hiPSC-RPE cells (236
POS signals ±21.20 SD per 0.05 mm2) (Fig. 5a). Quanti-
tative evaluation revealed a dramatic increase in
Fig. 5 Functional characterisation of hiPSC-RPE cells. a Analysis of
photoreceptor outer segment (POS) phagocytosis. Human iPSC-RPE
cells were incubated with Oregon green-labelled POS for 1.5, 6 and
24 h (about 20 POS per cell). ZO-1 apical staining (red) shows
relative localisation of the incorporated and partially digested POS.
Shown are x–y and x–z projections of monolayers of hiPSC-
RPE_WT1c1, passage 4, grown on transwell filters. Scale bars
20 lm. Due to known autofluorescence of POS, they are also visible
in the red channel. b Quantitative analysis of POS phagocytosis.
Incorporated POS were automatically counted in confocal images for
the three time points. Each bar represents the average ± SD of six
images, each covering an area of 0.05 mm2 (* = Student’s t test:
p B 0.05). c Measurement of apical and basal VEGF-A secretion in
hiPSC-RPE cell lines at different passages. VEGF-A secretion is
calculated as net VEGF-A levels in pg/ml. Each bar represents the
average ± SD of at least three biological replicates (* = Student’s
t test: p B 0.05). d Measurement of transepithelial resistance (TER)
in hiPSC-RPE cell lines tested at various passages. TER is calculated
as net X*cm2. Each data point represents the average ± SD of at
least three biological replicates
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phagocytotic activity from 1.5 to 6 h (762 POS signals
±26.51 SD per 0.05 mm2; p = 8.63E-07) which slowed
at 24 h (941 POS signals ±143.07 SD per 0.05 mm2;
p = 0.10, Fig. 5b). POS generally reveal a defined size
(approx. 4–6 lm in diameter) and a smooth, roundish
shape. At 24 h, more POS appeared partly digested and
degraded when compared to the 1.5- and 6-h time points
(Fig. 5a).
To elucidate whether hiPSC-RPE cells are capable of
secretion of known biomolecules, levels of VEGF-A were
measured in the apical and basal extracellular media of
hiPSC-RPE cells grown on transwell filter inserts for
2 months. VEGF-A was predominantly secreted into the
apical media compartment (hiPSC-RPE WT1c1 P3:
5,810 pg/ml ±1,339.78 SD) and showed a marked decline
with increased passaging (hiPSC-RPE WT1c1 P5:
1,593 pg/ml ±873.69 SD; p = 0.0083) (Fig. 5c).
As a third aspect of RPE function, transepithelial
resistance (TER) was determined in hiPSC-RPE cells cul-
tured on transwell filters. Weekly measurements were
taken over a 3-month period. Net TER demonstrated a
significant increase during the first 6–8 weeks for hiPSC-
RPE_WT1c4 at passage 2 (Fig. 5d). TER was maintained
at high levels in this cell line for at least another 12 weeks.
With increasing passages of hiPSC-RPE cells from passage
2 to passage 6, there was decline of TER (Fig. 5d). For all
cell lines analysed, there was a significant loss of TER to
below 300 X*cm2 after 24 weeks of cultivation (data not
shown).
Human iPSC-RPE Cells Largely Maintain Key
Structural and Functional Aspects After
Cryopreservation
For generation of cell repositories, cryostorage of hiPSC-
RPE cells would be ideal. Therefore, key structural and
functional aspects of cryopreserved hiPSC-RPE cells were
analysed. After thawing, cells expanded and developed
monolayers with characteristic hexagonal morphology
(data not shown).
Fig. 6 Structural and functional characterisation of hiPSC-RPE cells
after cryopreservation. a Antibody labelling against RPE-specific
marker BEST1 (green) and tight junction marker zonula occludens 1
(ZO-1, red). Endogenous BEST1 is targeted less efficiently to the
basolateral plasma membrane, whereas ZO-1 shows apical localisa-
tion. Shown are x–y and x–z projections of monolayers of polarised
hiPSC-RPE_WT1c1, passage 4, after cryostorage, grown on transwell
filters for 10 weeks. Scale bars 20 lm. b Quantitative analysis of
POS phagocytosis. Incorporated POS were automatically counted in
confocal images from continuously cultured hiPSC-RPE WT1c1
passage 4 and cryostored hiPSC-RPE WT1c1 passage 4. Each bar
represents the average ± SD of six images, each covering an area of
0.05 mm2 (* = Student’s t test: p B 0.05). c Measurement of apical
and basal VEGF-A secretion in hiPSC-RPE cell lines after cryostor-
age. VEGF-A secretion is calculated as net VEGF-A levels in pg/ml.
Each bar represents the average ± SD of at least three biological
replicates. d Measurement of transepithelial resistance (TER) in
hiPSC-RPE cell lines tested after cryostorage. TER is calculated as
net X*cm2. Each data point represents the average ± SD of at least
three biological replicates
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When cryostored hiPSC-RPE cells were grown polar-
ised on transwell filters for at least 2 months, confocal
microscopy verified BEST1 protein expression, but less
efficiently localised to the basolateral plasma membrane
(Fig. 6a). ZO-1 was detectable at the apical side of cryo-
stored hiPSC-RPE cells (Fig. 6a).
Phagocytotic properties of cryostored hiPSC-RPE cells
were directly compared to continuous hiPSC-RPE cells.
Therefore, POS at a concentration of 20 POS per cell were
fed to both continuous and cryostored hiPSC-RPE cells
cultured on transwell filters for 10 weeks. Uptake and
degradation activity was monitored after 24 h by confocal
microscopy. Incorporated POS were recorded automati-
cally in the confocal images for quantitative analysis
(Fig. 6b). Quantitative evaluation of POS feeding revealed
no statistically significant differences in phagocytotic
properties after 24 h (hiPSC-RPE WT1c1 P4: 613.67 POS
signals ±41.49 SD per 0.05 mm2; hiPSC-RPE WT1c1 P4
cryo: 542.34 POS signals ±46.92 SD per 0.05 mm2;
p = 0.12) (Fig. 6b).
VEGF-A secretion was measured in the apical and basal
extracellular media of cryostored hiPSC-RPE cells grown
on transwell filter inserts for 10 weeks. VEGF-A was
predominantly secreted into the apical media compartment
(Fig. 6c).
TER measurements of cryopreserved hiPSC-RPE cell
lines at passage 4 were performed weekly and observed a
strong increase during weeks 6–9 (Fig. 6d). TER was
maintained at high levels in this cell lines for another
8 weeks.
Discussion
In the present study, we demonstrated the successful
reprogramming of adult human dermal fibroblasts into
iPSCs via polycistronic lentiviral overexpression of tran-
scription factors OCT4, SOX2, KLF4 and L-Myc. The
iPSCs developed characteristic hESC-like morphology
including round, sharp-edged colonies with tightly packed
cells, and prominent nucleoli with a high ratio of nucleus to
cytoplasm volume (Takahashi et al. 2007). The iPSC mor-
phology was used as a basic indicator to initiate repro-
gramming and subcultivation. Additional RNA and protein
profiling revealed distinctive stem cell marker properties.
This is generally an accepted approach to characterise the
pluripotency of a stem cell line. The weak RNA expression
of endogenous OCT4 frequently found in our dermal fibro-
blast cell cultures is unexplained and, so far, has not been
reported in the literature. The faint expression of COL1A1 in
the hiPSCs could be due to re-differentiation of a few cells
and appears to be a regular observation (Takahashi and
Yamanaka 2006; Takahashi et al. 2007).
For a quick and comprehensive analysis of pluripotency
in the hiPSC lines, we used a commercial panel of specific,
well-known markers relative to a reference standard (Bock
et al. 2011). This includes genome-wide reference maps of
DNA methylation and gene expression for 20 previously
derived human ES cell lines and 12 human iPS cell lines. In
addition, the in vitro differentiation potential of these cell
lines was determined (Bock et al. 2011). Using this tool, we
show pluripotency of our hiPSC lines while the germ layer
markers indicate downregulation of endoderm and espe-
cially ectoderm markers. So far, we have not evaluated
differentiation of our hiPSC lines into other germ layers
than the RPE which arises ontogenetically from the neu-
roectoderm. The possibility that an altered germ layer
profile as determined in our experiment could influence the
effectiveness and quality of hiPSCs to differentiate in
certain cell types is unclear at present and needs system-
atically to be explored.
Monitoring of genomic integrity of hiPSCs is crucial,
particularly at early passages (Mayshar et al. 2010). It is
not uncommon that hiPSCs derived from fibroblasts
develop numerical or structural aberrations, limiting the
utility of such genetically unstable cell lines (Mayshar et al.
2010). Chromosomal aberrations could affect the differ-
entiation capacity of the cell line and are likely to influence
the interpretation of functional studies with differentiated
cells derived from genomically altered hiPSCs. Previous
studies show that hiPSCs can acquire chromosomal
abnormalities upon prolonged time in culture (Mayshar
et al. 2010). We made similar observations and found
chromosomal aberrations at passages higher than 20.
However, studies also reported aberrations present in early
passages with or without apparent somatic cell origin
(Mayshar et al. 2010). Therefore, we used early passage
hiPSCs for differentiation experiments, but not without
testing their chromosomal stability and the integrity of their
fibroblast origin.
Several protocols for RPE cell differentiation have been
described (Ukrohne et al. 2012; Buchholz et al. 2013; Zhu
et al. 2013; Rowland et al. 2013; Maruotti et al. 2013;
Singh et al. 2013b). We have slightly modified an earlier
protocol by Ukrohne et al. (2012) which proofed highly
efficient. Within 8 weeks, 25–40 differently sized pig-
mented cell clusters appeared within one 6-well of con-
fluent hiPSC colonies. By mechanically collecting these
pigmented clusters, we generally obtained homogenous
monolayer of pure RPE cells already after a single passage.
Only rarely did we find non-RPE, more fibroblast-shaped
cells after initial passaging. Interestingly, these cells were
no longer detectable after subsequent passages. Contami-
nation from undifferentiated hiPSCs is of particular con-
cern, since these cells can, by definition, proliferate and
form teratomas in host tissue (Schwartz et al. 2012). In our
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hands, coating cell culture surfaces with growth factor-
reduced Matrigel revealed better RPE growth and notably
less contamination with non-RPE cells than normal Ma-
trigel or hESC-qualified Matrigel at similar dilutions.
Differentiated RPE cells can either be grown on normal
cell culture surfaces or in 3D systems using filter mem-
branes which allow polar growth of cells (Ukrohne et al.
2012; Zhu et al. 2013). The latter mimics a more natural
situation and stimulates growth of native RPE cells
(Strauss 2005). For example, we show that polar growth on
transwell filters results in BEST1 protein expression at the
basolateral plasma membrane, whereas growth on equally
coated glass cover slips results in diffuse BEST1 protein
staining with less efficient localisation to the plasma
membrane. It should also be noted that in our experiments,
culturing of hiPSC-RPE cells on transwell filter was pos-
sible for several months before cells started to die, whereas
cells became apoptotic already after 6 weeks of cells cul-
tured on equally coated cell culture plates. Cells could also
successfully be detached enzymatically from filter mem-
branes and further subcultured. Therefore, for hiPSC-RPE
cells, we strongly prefer polarised growth on filter
membranes.
Highly differentiated hiPSC-RPE monolayers can
undergo serial expansion while retaining key cytological
and functional properties for a number of passages before
they reach replicative senescence (Singh et al. 2013a).
Attempting to passage cultures beyond senescence has
been demonstrated to greatly alter cellular characteristics.
Thus, knowledge of this passage ceiling is important when
preparing cultures for in vitro studies. It has also been
emphasised that culture systems vary widely, and there-
fore, the optimal passage and expansion range must be
determined for each culture method (Singh et al. 2013a). In
our experiments, we also observed replicative senescence
in hiPSC-RPE cell culture with alterations in cell mor-
phology, BEST1 expression and TER anomalies, but gen-
erally not before passage 6 in very contrast to an earlier
report where fundamental changes were already found at
passage 3 (Singh et al. 2013a).
Typical hexagonal morphology of pigmented cells is
unique for human RPE cells and on its own serves as an
important indicator for cell identity (Buchholz et al. 2009;
Singh et al. 2013a). Nevertheless, we set out to provide an
in-depth characterisation of structural and functional
aspects of hiPSC-RPE cells. Here, we also show by SEM
that hiPSC-RPE cells develop the typical microvilli at their
apical side. SEM analysis was performed with both low-
vac and high-vac mode. While low-vac mode in moist
conditions allows cells to better maintain their natural
environment than critical point drying and high-vac mode,
fluid on the cell surfaces, however, interfered with a clear
presentation of microvilli. In contrast, high-vac mode and
dry conditions fully revealed differentiation of the specia-
lised apical microvilli essential for most functions of the
native RPE, such as epithelial transport (Strauss 2005).
Our analysis also extended to immunostaining with
BEST1 antibodies. This protein has been shown to be
predominantly expressed in the human RPE, where it is
specifically localised at the basolateral plasma membrane
(Marmorstein et al. 2000; Stohr et al. 2002; Strauss 2005).
Interestingly, this protein is susceptible to culturing con-
ditions and usually stops expression within 5–6 days of
primary cell culture growth. Our study now showed that
high BEST1 expression was maintained for an extended
period of time in cell culture and for many passages on
transwell filters. In addition, both expression and localisa-
tion of BEST1 were comparable to native RPE cells when
grown for at least 2 months in culture. We additionally
confirmed BEST1 protein localisation by surface protein
biotinylation which only labels plasma membrane proteins
extending to the outside of the cell surface. Less than
2 months of cell culture revealed BEST1 immunostaining
partly cytosolic with only some protein localised to the
basolateral plasma membrane. This could indicate that
hiPSC-RPE cells require several weeks of maturation for
correct trafficking. When hiPSC-RPE cells finally reached
replicative senescence at passage 6, not only their hexag-
onal cell shape was altered but also BEST1 protein was
detected diffusely in the cytosol.
Formation of tight junctions is an essential feature of
RPE cells and required to maintain the blood–retina barrier
(Strauss 2005). Our results demonstrate presence of the
tight junction marker ZO-1 (Stevenson et al. 1986) at the
lateral apical side of hiPSC-RPE cells. This suggests for-
mation of operating tight junctions necessary for correct
RPE function and is also supported by a strong TER which
was build up with time in cell culture and generally
maintained at high levels in hiPSC-RPE cells. Replicative
senescence at passage 6 still revealed hiPSC-RPE cells
with regular ZO-1 labelling at the apical side, but TER
measurement showed a slow decline. This is likely due to
malfunctioning tight junctions and points to the validity of
TER recordings as a key functional parameter.
Secretion properties are characteristic for native RPE
(Strauss 2005) and have been previously described for
hiPSC-RPE cells (Singh et al. 2013a), underlining the
capacity of hiPSC-RPE to form functional, polarised
monolayers. In accordance with these previous findings, we
documented VEGF-A secretion in our hiPSC-RPE cell
lines. VEGF-A quantity decreased with increasing passage,
likely due to replicative senescence. As described previ-
ously, the majority of VEGF-A is secreted to the basal side
where it acts on the choroidal endothelium (Strauss 2005;
Singh et al. 2013a). Interestingly, we found higher apical
than basal secretion. This is likely due to our coating
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method of filter inserts which might reduce basal VEGF-A
amount and needs further investigation.
Phagocytosis of POS is another key function of RPE cells
(Strauss 2005). In the present study, we verified phagocy-
totic properties of hiPSC-RPE cells in a timeline experiment
and visualised the intracellular location and degradation of
POS by immunofluorescence and confocal microscopy. Due
to known autofluorescence of POS (Chang and Finnemann
2007; Lei et al. 2012), they were not only visible in the green
channel, but also in the red channel. For statistical evaluation
of POS incorporation, we only used images taken in the
green channel. We observed a statistically significant
increase in phagocytotic activity during the first 6 h.
Between 6 and 24 h, there was a slight rise in the number of
incorporated POS, although statistically not significant. This
could be indicative of a saturation effect, beginning after 6 h
of incubation with POS. Calculations indicate that after 24 h
feeding with 20 POS per cell, each hiPSC-RPE cell should
have incorporated two POS. In other words, 10 % of POS in
the medium should be incorporated. As expected, we
observed more partly digested and degraded POS which had
lost their typical size and shape after 24 h than after 6 h of
POS feeding.
Some of our experiments focused on long-term storage
of hiPSC-RPE cells. For the purpose of establishing cell
repositories of disease- or patient-specific cell lines,
fibroblasts or hiPSC lines can be cryostored. Nevertheless,
it would be more feasible to directly cryopreserve hiPSC-
RPE as the target cells of interest. We therefore not only
tested whether hiPSC-RPE cells were vital after cryopres-
ervation, but also characterised their key structural and
functional properties. Confocal microscopy verified
BEST1 protein expression, but less efficiently localised to
the basolateral plasma membrane compared to hiPSC-RPE
cells without prior cryofreezing. Phagocytotic properties
were not altered by cryopreservation. We directly com-
pared continuously cultured cells to cryopreserved cells in
the same experimental set-up and detected a generally
lower phagocytotic activity after 24 h than in the timeline
experiment. This underlines inter-experimental fluctuation
and the importance of adequate controls. VEGF-A was
secreted by cryostored hiPSC-RPE cells, but in lower
amounts compared to continuous hiPSC-RPE cells. We
moreover found a later but equally strong increase of TER
in cryostored hiPSC-RPE cells, indicating a similar TER
pattern as identified for continuous hiPSC-RPE cells. In
conclusion, it seems best to use fresh, continuously cul-
tured hiPSC-RPE cells, but cryopreserved hiPSC-RPE cells
largely maintain key structural and functional aspects and
can therefore serve as a reliable cellular resource.
In summary, our data demonstrate the successful
reprogramming of human adult skin biopsy-derived fibro-
blasts to hiPSCs. We further established the generation of
pure, expandable and cryostorable RPE cells from cultures
of differentiating hiPSCs with high efficiency for further
evaluation of structural and functional capabilities. In all
aspects analysed, hiPSC-RPE cells were found to show
structural and functional features characteristic for native
RPE and thus hold tremendous potential as a tool for dis-
ease modelling in selected human ocular diseases with
primary RPE pathology.
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